Veradermics Inc share price logo

Veradermics Inc Share Price

NYSE: MANE

Mid Cap

$63.67

+1.75

(+2.83%)

as on

Veradermics Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $62.79
    $66.20
    downward going graph

    1.38%

    Downside

    3.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Veradermics Inc share price movements today

Previous Close
$61.92
Open
$62.79
Volume
558.6K
Day's Low - High
$62.79 - $66.20

Veradermics Inc Historical Returns

1 Month Return
+ 46.83 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Veradermics Inc Stock Fundamentals & Key Indicators

Check Veradermics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.1B

EPS (TTM)

-2.167

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Veradermics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veradermics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$2.1BNANA0.00%
BUY$41.4B126.75%133.418.45%
BUY$115.3B112.49%29.6832.94%
NA$31.6BNA1115.37%
BUY$77.5B58.91%17.6731.41%

Veradermics Inc Stock’s Investor Sentiment and Interest

Search interest for Veradermics Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Veradermics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Total Revenue
-
Gross Profit
-
Operating Income
-5
EBITDA
-5
Interest Expense
0
Depreciation
-
Income Before Tax
-5
Income Tax Expense
-
Net Income
-5
Net Profit Margin
0.00%

Veradermics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-17
-26
EBITDA
-16
-25
Interest Expense
0
0
Depreciation
-
-
Income Before Tax
-16
-26
Income Tax Expense
-
-
Net Income
-16
-26
Net Profit Margin
0.00%
0.00%

Veradermics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2024
Net Income
-26
Operating Cash Flow
-23
Investing Cash Flow
-
Financing Cash Flow
60
Change in Cash
36

Insights on Veradermics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MANE stock has moved up by 4.9%

About Veradermics Inc

Veradermics, Incorporated is a late clinical-stage biopharmaceutical company. The Company is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The Company is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss therapy and potentially transform PHL treatment. VDPHL01 is an oral, ER formulation of minoxidil, a proven hair growth agent, designed to maximize minoxidil’s impact on hair restoration while minimizing the risk of cardiac activity. The Company is conducting a Phase II clinical trial evaluating VDPHL01 in male and female patients with mild-to-moderate PHL.
OrganisationVeradermics Inc
Headquarters470 James Street, New Haven, CT, United States, 06513
CEODr. Reid Waldman M.D.
E-voting on sharesClick here to vote

Key Management of Veradermics Inc

Name

Title

Dr. Timothy Durso M.D.

Chief Technical Officer

Mr. Michael V. Greco J.D.

General Counsel & Secretary

Mr. Karl Pruss

Senior Director of Manufacturing Sciences & Technology

Dr. Michael Smolinski Ph.D.

Vice President of Development & Scientific Operations

Mr. Aron Shapiro

Vice President of Clinical Development & Regulatory Affairs

Dr. Reid Waldman M.D.

CEO & Director

Mr. Michael Murphy R.Ph.

VP of Project & Program Management of Business Technology and Chief of Staff

Mr. Mark Neumann

Chief Commercial & Strategy Officer

Ms. Erika Sipperly CPA

Controller

Mr. Dominic Carrano CPA

CFO & Treasurer

FAQs

What is Veradermics Inc share price today?

Veradermics Inc share price today is $63.67 as on at the close of the market. Veradermics Inc share today touched a day high of $66.2 and a low of $62.79.

What is the 52 week high and 52 week low for Veradermics Inc share?

Veradermics Inc share touched a 52 week high of $ on and a 52 week low of $ on . Veradermics Inc stock price today i.e. is closed at $63.67,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Veradermics Inc's market capitalisation today?

Veradermics Inc market capitalisation is $0.00T as on .

How to invest in Veradermics Inc Stock (MANE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Veradermics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veradermics Inc Shares that will get you 0.0236 shares as per Veradermics Inc share price of $63.67 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Veradermics Inc Stock (MANE) from India?

Indian investors can start investing in Veradermics Inc (MANE) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Veradermics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Veradermics Inc share’s latest price of $63.67 as on March 25, 2026 at 1:29 am IST, you will get 0.1571 shares of Veradermics Inc. Learn more about fractional shares .